E-Mycin

Gastroparesis, Erythrasma, Whooping Cough + 60 more
Treatment
68 FDA approvals
20 Active Studies for E-Mycin

What is E-Mycin

ErythromycinThe Generic name of this drug
Treatment SummaryErythromycin is an antibiotic used to treat various bacterial infections. It is a type of macrolide antibiotic, which includes drugs like Azithromycin, Clarithromycin, and Spiramycin. Erythromycin was first discovered in 1952 and can be administered through intravenous, topical, or eye drop preparations.
Erythrocin Stearateis the brand name
image of different drug pills on a surface
E-Mycin Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Erythrocin Stearate
Erythromycin
1964
261

Approved as Treatment by the FDA

Erythromycin, also known as Erythrocin Stearate, is approved by the FDA for 68 uses which include Bordetella Pertussis Infection and Urinary Tract Infection (UTI) .
Bordetella Pertussis Infection
Urinary Tract Infection (UTI)
Haemophilus Influenzae Infections
Used to treat Haemophilus Influenzae Infections in combination with null
Corynebacterium Infections
Legionella pneumophila
diphtheria antitoxin
Urethritis
Communicable Diseases
Corynebacterium Infections
Acne Vulgaris
Used to treat predominant skin comedones, papules and pustules in combination with Tretinoin
Listeria infection
Listeria monocytogenes infection
Urethritis
Bacterial Infections
Streptococcus Pneumoniae Infections
Postoperative Infections
Communicable Diseases
uncomplicated endocervical infection
Urethritis
Pertussis
Respiratory Tract Infections
Pneumonia, Mycoplasma
Upper Respiratory Tract Infection
Streptococcus pyogenes
Listeriosis
Ureaplasma urethritis
Communicable Diseases
Bacterial Infections
Whooping Cough
Pneumonia
Amebiasis
Recurrent Upper and Lower Respiratory Tract Infections (RTIs)
prophylaxis of Postoperative Infections
Communicable Diseases
Staphylococcal Skin Infections
Skin and skin structure infections
Diphtheria
Primary Syphilis
Lower Respiratory Tract Infection (LRTI)
Acne Vulgaris
Used to treat Acne Vulgaris in combination with Tretinoin
Acute Otitis Media caused by Haemophilus Influenzae
Used to treat Acute Otitis Media caused by Haemophilus Influenzae in combination with Sulfisoxazole
Common Cold
Corynebacterium minutissimum infection
prophylaxis of Rheumatic fever
penicillins
Rheumatic Fever
Intestinal amebiasis caused by entamoeba histolytica
Conjunctivitis
Staphylococcal Skin Infections
Erythrasma
Whooping Cough
Bronchitis
skin and subcutaneous tissue bacterial infections caused by streptococcus pyogenes
penicillins
Staphylococcus (S.) Aureus Infection
Ureaplasma urealyticum
pustular lesions
Used to treat pustular lesions in combination with Avobenzone
urogenital infections during pregnancy
inflammatory papular lesions
Used to treat inflammatory papular lesions in combination with Avobenzone
treponema pallidum infection
Whooping Cough
Chlamydia Trachomatis
patients with intolerance or contraindications to tetracycline use
Syphilis
First episode of rheumatic fever
Rheumatic Fever
Pneumococcal Infections
Sulfonamides

Effectiveness

How E-Mycin Affects PatientsErythromycin is an antibiotic used to treat bacterial infections. It works by blocking the production of proteins in bacteria, which stops them from multiplying and spreading. Erythromycin has been shown to be effective against certain bacteria, but it is important to test for drug-resistance before administering the antibiotic. Combining erythromycin with sulfonamides can be effective against resistant Haemophilus influenzae. It is possible to experience side effects such as pseudomembranous colitis and liver dysfunction when taking erythromycin, so it is important to monitor for these symptoms.
How E-Mycin works in the bodyErythromycin works by preventing bacteria from replicating. It does this by interfering with the protein-making process that bacteria need to reproduce. Erythromycin binds to ribosomal RNA molecules, which are necessary for bacterial protein synthesis. By binding to these molecules, it prevents the assembly of the 50S ribosomal subunit, thus halting bacterial protein synthesis. This results in the effective control of various bacterial infections.

When to interrupt dosage

The proposed dosage of E-Mycin is contingent upon the diagnosed condition, including Chlamydia Trachomatis, penicillins and Syphilis. The dose can differ, depending on the means of administration (e.g. Granule, for suspension or Tablet, film coated - Oral) as specified in the table below.
Condition
Dosage
Administration
Gastroparesis
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Solution, Topical, Solution - Topical, Gel, Gel - Topical, Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release, Capsule, delayed release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Ointment, Ophthalmic, Ointment - Ophthalmic, Granule, for suspension - Oral, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Granule, for suspension, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Liquid, Liquid - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Powder, Powder - Oral, Lotion, Lotion - Topical, Lotion; Swab, Lotion; Swab - Topical, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab - Topical, Swab, For suspension, For suspension - Oral, Tablet, coated, Tablet, coated - Oral
Whooping Cough
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Solution, Topical, Solution - Topical, Gel, Gel - Topical, Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release, Capsule, delayed release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Ointment, Ophthalmic, Ointment - Ophthalmic, Granule, for suspension - Oral, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Granule, for suspension, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Liquid, Liquid - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Powder, Powder - Oral, Lotion, Lotion - Topical, Lotion; Swab, Lotion; Swab - Topical, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab - Topical, Swab, For suspension, For suspension - Oral, Tablet, coated, Tablet, coated - Oral
Erythrasma
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Solution, Topical, Solution - Topical, Gel, Gel - Topical, Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release, Capsule, delayed release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Ointment, Ophthalmic, Ointment - Ophthalmic, Granule, for suspension - Oral, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Granule, for suspension, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Liquid, Liquid - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Powder, Powder - Oral, Lotion, Lotion - Topical, Lotion; Swab, Lotion; Swab - Topical, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab - Topical, Swab, For suspension, For suspension - Oral, Tablet, coated, Tablet, coated - Oral
Diphtheria
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Solution, Topical, Solution - Topical, Gel, Gel - Topical, Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release, Capsule, delayed release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Ointment, Ophthalmic, Ointment - Ophthalmic, Granule, for suspension - Oral, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Granule, for suspension, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Liquid, Liquid - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Powder, Powder - Oral, Lotion, Lotion - Topical, Lotion; Swab, Lotion; Swab - Topical, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab - Topical, Swab, For suspension, For suspension - Oral, Tablet, coated, Tablet, coated - Oral
Chancroid
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Solution, Topical, Solution - Topical, Gel, Gel - Topical, Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release, Capsule, delayed release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Ointment, Ophthalmic, Ointment - Ophthalmic, Granule, for suspension - Oral, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Granule, for suspension, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Liquid, Liquid - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Powder, Powder - Oral, Lotion, Lotion - Topical, Lotion; Swab, Lotion; Swab - Topical, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab - Topical, Swab, For suspension, For suspension - Oral, Tablet, coated, Tablet, coated - Oral
Lymphogranuloma Venereum
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Solution, Topical, Solution - Topical, Gel, Gel - Topical, Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release, Capsule, delayed release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Ointment, Ophthalmic, Ointment - Ophthalmic, Granule, for suspension - Oral, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Granule, for suspension, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Liquid, Liquid - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Powder, Powder - Oral, Lotion, Lotion - Topical, Lotion; Swab, Lotion; Swab - Topical, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab - Topical, Swab, For suspension, For suspension - Oral, Tablet, coated, Tablet, coated - Oral
Granuloma Inguinale
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Solution, Topical, Solution - Topical, Gel, Gel - Topical, Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release, Capsule, delayed release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Ointment, Ophthalmic, Ointment - Ophthalmic, Granule, for suspension - Oral, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Granule, for suspension, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Liquid, Liquid - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Powder, Powder - Oral, Lotion, Lotion - Topical, Lotion; Swab, Lotion; Swab - Topical, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab - Topical, Swab, For suspension, For suspension - Oral, Tablet, coated, Tablet, coated - Oral
Syphilis
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Solution, Topical, Solution - Topical, Gel, Gel - Topical, Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release, Capsule, delayed release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Ointment, Ophthalmic, Ointment - Ophthalmic, Granule, for suspension - Oral, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Granule, for suspension, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Liquid, Liquid - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Powder, Powder - Oral, Lotion, Lotion - Topical, Lotion; Swab, Lotion; Swab - Topical, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab - Topical, Swab, For suspension, For suspension - Oral, Tablet, coated, Tablet, coated - Oral
Urethritis
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Solution, Topical, Solution - Topical, Gel, Gel - Topical, Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release, Capsule, delayed release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Ointment, Ophthalmic, Ointment - Ophthalmic, Granule, for suspension - Oral, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Granule, for suspension, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Liquid, Liquid - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Powder, Powder - Oral, Lotion, Lotion - Topical, Lotion; Swab, Lotion; Swab - Topical, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab - Topical, Swab, For suspension, For suspension - Oral, Tablet, coated, Tablet, coated - Oral
Whooping Cough
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Solution, Topical, Solution - Topical, Gel, Gel - Topical, Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release, Capsule, delayed release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Ointment, Ophthalmic, Ointment - Ophthalmic, Granule, for suspension - Oral, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Granule, for suspension, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Liquid, Liquid - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Powder, Powder - Oral, Lotion, Lotion - Topical, Lotion; Swab, Lotion; Swab - Topical, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab - Topical, Swab, For suspension, For suspension - Oral, Tablet, coated, Tablet, coated - Oral
Acne Vulgaris
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Solution, Topical, Solution - Topical, Gel, Gel - Topical, Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release, Capsule, delayed release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Ointment, Ophthalmic, Ointment - Ophthalmic, Granule, for suspension - Oral, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Granule, for suspension, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Liquid, Liquid - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Powder, Powder - Oral, Lotion, Lotion - Topical, Lotion; Swab, Lotion; Swab - Topical, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab - Topical, Swab, For suspension, For suspension - Oral, Tablet, coated, Tablet, coated - Oral
Listeriosis
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Solution, Topical, Solution - Topical, Gel, Gel - Topical, Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release, Capsule, delayed release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Ointment, Ophthalmic, Ointment - Ophthalmic, Granule, for suspension - Oral, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Granule, for suspension, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Liquid, Liquid - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Powder, Powder - Oral, Lotion, Lotion - Topical, Lotion; Swab, Lotion; Swab - Topical, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab - Topical, Swab, For suspension, For suspension - Oral, Tablet, coated, Tablet, coated - Oral
Bacterial Infections
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Solution, Topical, Solution - Topical, Gel, Gel - Topical, Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release, Capsule, delayed release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Ointment, Ophthalmic, Ointment - Ophthalmic, Granule, for suspension - Oral, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Granule, for suspension, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Liquid, Liquid - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Powder, Powder - Oral, Lotion, Lotion - Topical, Lotion; Swab, Lotion; Swab - Topical, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab - Topical, Swab, For suspension, For suspension - Oral, Tablet, coated, Tablet, coated - Oral
Acne Vulgaris
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Solution, Topical, Solution - Topical, Gel, Gel - Topical, Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release, Capsule, delayed release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Ointment, Ophthalmic, Ointment - Ophthalmic, Granule, for suspension - Oral, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Granule, for suspension, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Liquid, Liquid - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Powder, Powder - Oral, Lotion, Lotion - Topical, Lotion; Swab, Lotion; Swab - Topical, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab - Topical, Swab, For suspension, For suspension - Oral, Tablet, coated, Tablet, coated - Oral
Endophthalmitis
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Solution, Topical, Solution - Topical, Gel, Gel - Topical, Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release, Capsule, delayed release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Ointment, Ophthalmic, Ointment - Ophthalmic, Granule, for suspension - Oral, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Granule, for suspension, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Liquid, Liquid - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Powder, Powder - Oral, Lotion, Lotion - Topical, Lotion; Swab, Lotion; Swab - Topical, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab - Topical, Swab, For suspension, For suspension - Oral, Tablet, coated, Tablet, coated - Oral
Ophthalmia neonatorum (gonococcal)
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Solution, Topical, Solution - Topical, Gel, Gel - Topical, Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release, Capsule, delayed release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Ointment, Ophthalmic, Ointment - Ophthalmic, Granule, for suspension - Oral, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Granule, for suspension, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Liquid, Liquid - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Powder, Powder - Oral, Lotion, Lotion - Topical, Lotion; Swab, Lotion; Swab - Topical, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab - Topical, Swab, For suspension, For suspension - Oral, Tablet, coated, Tablet, coated - Oral
Conjunctivitis
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Solution, Topical, Solution - Topical, Gel, Gel - Topical, Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release, Capsule, delayed release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Ointment, Ophthalmic, Ointment - Ophthalmic, Granule, for suspension - Oral, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Granule, for suspension, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Liquid, Liquid - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Powder, Powder - Oral, Lotion, Lotion - Topical, Lotion; Swab, Lotion; Swab - Topical, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab - Topical, Swab, For suspension, For suspension - Oral, Tablet, coated, Tablet, coated - Oral
Respiratory Tract Infections
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Solution, Topical, Solution - Topical, Gel, Gel - Topical, Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release, Capsule, delayed release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Ointment, Ophthalmic, Ointment - Ophthalmic, Granule, for suspension - Oral, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Granule, for suspension, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Liquid, Liquid - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Powder, Powder - Oral, Lotion, Lotion - Topical, Lotion; Swab, Lotion; Swab - Topical, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab - Topical, Swab, For suspension, For suspension - Oral, Tablet, coated, Tablet, coated - Oral
Amebiasis
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Solution, Topical, Solution - Topical, Gel, Gel - Topical, Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release, Capsule, delayed release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Ointment, Ophthalmic, Ointment - Ophthalmic, Granule, for suspension - Oral, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Granule, for suspension, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Liquid, Liquid - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Powder, Powder - Oral, Lotion, Lotion - Topical, Lotion; Swab, Lotion; Swab - Topical, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab - Topical, Swab, For suspension, For suspension - Oral, Tablet, coated, Tablet, coated - Oral
Acne Vulgaris
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Solution, Topical, Solution - Topical, Gel, Gel - Topical, Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release, Capsule, delayed release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Ointment, Ophthalmic, Ointment - Ophthalmic, Granule, for suspension - Oral, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Granule, for suspension, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Liquid, Liquid - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Powder, Powder - Oral, Lotion, Lotion - Topical, Lotion; Swab, Lotion; Swab - Topical, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Capsule, Delayed Release, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab - Topical, Swab, For suspension, For suspension - Oral, Tablet, coated, Tablet, coated - Oral

Warnings

E-Mycin Contraindications
Condition
Risk Level
Notes
Severe Hypersensitivity Reactions
Do Not Combine
Erythromycin may interact with Pulse Frequency
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
There are 20 known major drug interactions with E-Mycin.
Common E-Mycin Drug Interactions
Drug Name
Risk Level
Description
Abemaciclib
Major
The serum concentration of Abemaciclib can be increased when it is combined with Erythromycin.
Acalabrutinib
Major
The metabolism of Acalabrutinib can be decreased when combined with Erythromycin.
Alectinib
Major
The metabolism of Alectinib can be decreased when combined with Erythromycin.
Alpelisib
Major
The metabolism of Alpelisib can be decreased when combined with Erythromycin.
Aminophylline
Major
The metabolism of Aminophylline can be decreased when combined with Erythromycin.
E-Mycin Toxicity & Overdose RiskThe toxic dose of erythromycin in rats is 9272mg/kg. Overdosing on erythromycin may cause diarrhea, nausea, stomach cramps, and vomiting. If an overdose is suspected, discontinue the drug immediately and seek medical help. Erythromycin cannot be removed from the body using dialysis.

E-Mycin Novel Uses: Which Conditions Have a Clinical Trial Featuring E-Mycin?

Currently, 53 active clinical trials are being conducted to explore the use of E-Mycin to address Streptococcus pyogenes, Treponema pallidum infection and Rheumatic Fever.
Condition
Clinical Trials
Trial Phases
Listeria monocytogenes infection
0 Actively Recruiting
Respiratory Tract Infections
0 Actively Recruiting
Pneumococcal Infections
0 Actively Recruiting
Conjunctivitis
0 Actively Recruiting
Acne Vulgaris
9 Actively Recruiting
Phase 1, Phase 2, Not Applicable, Early Phase 1, Phase 4
penicillins
2 Actively Recruiting
Early Phase 1, Phase 3
Acne Vulgaris
0 Actively Recruiting
Primary Syphilis
0 Actively Recruiting
pustular lesions
0 Actively Recruiting
Acne Vulgaris
0 Actively Recruiting
First episode of rheumatic fever
0 Actively Recruiting
Acute Otitis Media caused by Haemophilus Influenzae
0 Actively Recruiting
Communicable Diseases
0 Actively Recruiting
diphtheria antitoxin
0 Actively Recruiting
Corynebacterium minutissimum infection
0 Actively Recruiting
Gastroparesis
19 Actively Recruiting
Phase 3, Not Applicable, Early Phase 1, Phase 2, Phase 1
Streptococcus pyogenes
0 Actively Recruiting
Whooping Cough
0 Actively Recruiting
Common Cold
3 Actively Recruiting
Not Applicable
Listeriosis
0 Actively Recruiting

E-Mycin Reviews: What are patients saying about E-Mycin?

5Patient Review
7/24/2015
E-Mycin for Middle Ear Infection
This antibiotic was terrible. The abdominal pain it caused was much worse than the flu it was prescribed for. If offered, tell them to try again...
4.7Patient Review
4/27/2011
E-Mycin for Bacterial Stomach or Intestine Infection caused by Anthrax
Unfortunately, this medication caused me a lot of pain in my stomach. Even when I took it with meals, I experienced cramping and nausea. I had to call my doctor to ask for something different.
4.7Patient Review
7/12/2012
E-Mycin for Skin Infection
I had some pretty intense cold sweats, nausea and hallucinations.
4.7Patient Review
5/30/2016
E-Mycin for Skin Infection
I saw results from this treatment within a day, though my appetite decreased while I was taking it.
4Patient Review
7/28/2015
E-Mycin for Whooping Cough
I experienced zero negative side effects from this treatment!
View All Reviews
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about e-mycin

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is e-Mycin a penicillin?

"E-Mycin is an antibiotic that is effective against patients with a history of rheumatic disease who are allergic to penicillin antibiotics."

Answered by AI

What does e-Mycin stand for?

"Erythromycin is a type of antibiotic that is used to treat infections caused by bacteria. Erythromycin belongs to a class of drugs called macrolide antibiotics, which work by either killing the bacteria that cause an infection or by stopping the growth of the bacteria."

Answered by AI

Which side effect is common of e-Mycin?

"The serious side effect of this drug is a skin rash. However, other side effects may include severe stomach pain, yellowing of the skin or whites of the eyes, or pale feces with dark urine. These could be signs of problems with the pancreas, liver, or gallbladder."

Answered by AI

What is e-Mycin used to treat?

"It is used to treat certain bacterial infections, to control acne in addition to other acne treatments, and to prevent infections in people with a history of rheumatic disease, congenital heart disease or other acquired valvular heart disease and who are allergic to penicillin antibiotics."

Answered by AI

Clinical Trials for E-Mycin

Have you considered E-Mycin clinical trials? We made a collection of clinical trials featuring E-Mycin, we think they might fit your search criteria.
Have you considered E-Mycin clinical trials? We made a collection of clinical trials featuring E-Mycin, we think they might fit your search criteria.
Have you considered E-Mycin clinical trials? We made a collection of clinical trials featuring E-Mycin, we think they might fit your search criteria.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top